Cargando…
Current State of “Omics” Biomarkers in Pancreatic Cancer
Pancreatic cancer is one of the most fatal malignancies and the seventh leading cause of cancer-related deaths related to late diagnosis, poor survival rates, and high incidence of metastasis. Unfortunately, pancreatic cancer is predicted to become the third leading cause of cancer deaths in the fut...
Autores principales: | Turanli, Beste, Yildirim, Esra, Gulfidan, Gizem, Arga, Kazim Yalcin, Sinha, Raghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918884/ https://www.ncbi.nlm.nih.gov/pubmed/33672926 http://dx.doi.org/10.3390/jpm11020127 |
Ejemplares similares
-
Pan-cancer mapping of differential protein-protein interactions
por: Gulfidan, Gizem, et al.
Publicado: (2020) -
Systems-level biomarkers identification and drug repositioning in colorectal cancer
por: Beklen, Hande, et al.
Publicado: (2021) -
Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020) -
Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas
por: Caliskan, Aysegul, et al.
Publicado: (2021) -
Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
por: Beklen, Hande, et al.
Publicado: (2021)